+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca therapy in patients with cystic fibrosis cf and liver disease a dose response study



Ursodeoxycholic acid udca therapy in patients with cystic fibrosis cf and liver disease a dose response study



Gastroenterology 100(5 Part 2): A731




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144958

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose-response study. Hepatology 16(4): 924-930, 1992

Markedly decreased biliary ursodeoxycholic acid enrichment with high dose UDCA in cystic fibrosis associated liver disease Optimization of the therapeutic dose. Hepatology 20(4 Part 2): 262A, 1994

The effect of ursodeoxycholic acid udca on liver function and bile acid metabolism in patients with cystic fibrosis cf and liver disease. Hepatology 10(4): 726, 1989

Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis. Gastroenterology 96(5 Part 2): A586, 1989

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up. Scandinavian Journal of Gastroenterology 32(4): 369-373, 1997

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 12(2): 322-334, 1990

Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease. Journal of Pediatrics 177: 59-65.E1, 2016

Effects of ursodeoxycholic acid udca on liver function tests and bile acid metabolism in anicteric primary biliary cirrhosis pbc a dose response study. Hepatology 8(5): 1266, 1988

Amelioration of cholestasis and nutritional state in patients with cystic fibrosis cf treated with ursodeoxycholic acid udca. Journal of Hepatology 9(Suppl. 1): S21, 1989

Ursodeoxycholic acid therapy in cystic fibrosis liver disease – a retrospective long?term follow?up case?control study. Alimentary Pharmacology & Therapeutics 36(3), 2012

Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study. Alimentary Pharmacology and Therapeutics 36(3): 266-273, 2012

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease. Journal of Hepatology 31(4): 672-677, 1999

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. Journal of Pediatrics 117(3): 482-489, 1990

Treatment with ursodeoxycholic acid for patients with cystic fibrosis and liver disease. Escobar, H, Baquero, F, Suarez, L International Congress Series; Clinical ecology of cystic fibrosis 275-279, 1993